StockDriftsStockDriftsTop 33 Catalio Capital Management LP Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| JNJ | JOHNSON & JOHNSON | 6.63% | 138.9K | $35.3M | new | $202.97(+29.12%) | 2026-06-30 | |
| GILD | GILEAD SCIENCES INC | 6.39% | 269.3K | $34.0M | +64.31%(+105.40K) | $119.89(+15.22%) | 2026-06-30 | |
| BBIO | BRIDGEBIO PHARMA INC | 6.37% | 455.0K | $33.9M | +5.33%(+23.03K) | $29.04(+179.65%) | 2026-06-30 | |
| SNDX | SYNDAX PHARMACEUTICALS INC | 4.99% | 1.22M | $26.6M | +16.48%(+172.03K) | $13.86(+37.65%) | 2026-06-30 | |
| DFTX | DEFINIUM THERAPEUTICS INC | 4.97% | 562.7K | $26.5M | -45.79%(-475.31K) | $16.14(+171.91%) | 2026-06-30 | |
| BMY | BRISTOL-MYERS SQUIBB CO | 4.47% | 413.0K | $23.8M | -1.85%(-7.77K) | $53.09(+21.78%) | 2026-06-30 | |
| NTRA | NATERA INC | 4.19% | 82.2K | $22.3M | +15.90%(+11.27K) | $174.74(+77.85%) | 2026-06-30 | |
| INCY | INCYTE CORP | 4.08% | 191.6K | $21.7M | +5.23%(+9.53K) | $96.71(+24.62%) | 2026-06-30 | |
| SEPN | SEPTERNA INC | 3.37% | 536.2K | $18.0M | +82.14%(+241.79K) | $25.38(+87.46%) | 2026-06-30 | |
| MLYS | MINERALYS THERAPEUTICS INC | 3.29% | 648.7K | $17.5M | +47.76%(+209.68K) | $32.38(-19.42%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (6 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | — | — | — | — | +63.69% |
| Top 20 Holdings Unweighted | — | — | — | — | +86.49% |
Catalio Capital Management LP reports $532.10M in US-listed equity holdings across 39 positions in its most recent 13F filing. Its largest disclosed positions are JNJ (6.6%), GILD (6.4%) and BBIO (6.4%). The top 20 holdings account for 71.51% of reported assets. Its disclosed equity book has returned +63.69% cumulatively over 6 quarters. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Catalio Capital Management LP, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Catalio Capital Management LP’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1958125). View Catalio Capital Management LP’s 13F filings on SEC